2020 American Headache Society (AHS) Virtual Annual Scientific Meeting

Impel presented four scientific abstracts as part of the 2020 American Headache Society Virtual Annual Scientific Meeting, including findings from our pivotal Phase 3 STOP 301 study which illustrate INP104’s potential to become an important new option for patients in the treatment of acute migraine.